Senlin Li
Guangdong Provincial Key Laboratory Of Malignant Tumor Epigenetics And Gene Regulation
Guangzhou, 510120, China
Guangzhou, 510120, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Modulating lipid metabolism by nanoparticles (NPs)-mediated ACSL3 silencing to inhibit hepatocellular carcinoma growth and metastasis.
Journal: Molecular cancer
Published: September 11, 2024
Remodeling Serine Synthesis and Metabolism via Nanoparticles (NPs)-Mediated CFL1 Silencing to Enhance the Sensitivity of Hepatocellular Carcinoma to Sorafenib.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 02, 2022
Sorafenib plus hepatic arterial infusion chemotherapy versus sorafenib alone for advanced hepatocellular carcinoma: A systematic review and meta-analysis.
Journal: Journal of gastroenterology and hepatology
Published: August 30, 2022
Nanoparticles (NPs)-mediated systemic mRNA delivery to reverse trastuzumab resistance for effective breast cancer therapy.
Journal: Acta pharmaceutica Sinica. B
Published: May 28, 2022
Concurrent silencing of TBCE and drug delivery to overcome platinum-based resistance in liver cancer.
Journal: Acta pharmaceutica Sinica. B
Published: December 04, 2021
A siRNA-Assisted Assembly Strategy to Simultaneously Suppress "Self" and Upregulate "Eat-Me" Signals for Nanoenabled Chemo-Immunotherapy.
Journal: ACS nano
Published: September 21, 2021
A tumor microenvironment (TME)-responsive nanoplatform for systemic saporin delivery and effective breast cancer therapy.
Journal: Chemical communications (Cambridge, England)
Published: February 15, 2021
Nanocarrier-mediated antioxidant delivery for liver diseases.
Journal: Theranostics
Published: July 29, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026